Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
Journal of medicinal chemistry·1998
Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation.
British journal of pharmacology·1998
Genes, fuel, and fate in lung cancer.
Biochemical Society transactions·2026
Obesity-associated inflammation and cancer: molecular mechanisms, evidence gaps, and therapeutic opportunities.
Frontiers in immunology·2026
A novel rat model of ovarian cancer and cisplatin chemotherapy-related cognitive impairment.
Brain, behavior, & immunity - health·2026
Protein kinase WEE1 promotes cardiomyocytes ferroptosis and cardiac hypertrophy via the NF-κB/LCN2 axis.
Acta pharmacologica Sinica·2026